scholarly article | Q13442814 |
P2093 | author name string | Zhao X | |
Wang KK | |||
Hayes RL | |||
Posmantur RM | |||
Pike BR | |||
Newcomb JK | |||
P433 | issue | 11 | |
P921 | main subject | proteolysis | Q33123 |
traumatic brain injury | Q1995526 | ||
P304 | page(s) | 2437-2442 | |
P577 | publication date | 1998-08-01 | |
P1433 | published in | NeuroReport | Q15710007 |
P1476 | title | Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury | |
P478 | volume | 9 |
Q34686666 | A novel strategy to activate cytoprotective genes in the injured brain |
Q48109532 | Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats |
Q48770448 | Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats |
Q78060140 | Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury |
Q42788353 | Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury |
Q35831901 | Alterations of A-type potassium channels in hippocampal neurons after traumatic brain injury |
Q40514538 | Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. |
Q24802137 | Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury |
Q37425364 | Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion |
Q38109663 | Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review |
Q45061432 | Biomarkers in the clinical diagnosis and management of traumatic brain injury |
Q38623128 | Biomarkers in traumatic brain injury: a review. |
Q37473431 | Biomarkers of blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast brain injury. |
Q35802481 | Biomarkers of proteolytic damage following traumatic brain injury |
Q36912518 | Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse |
Q73011088 | Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury |
Q40723358 | Calpain activation in Huntington's disease. |
Q33815206 | Calpain and caspase: can you tell the difference? |
Q37686765 | Calpain as a therapeutic target in traumatic brain injury |
Q47370941 | Calpain-2 as a therapeutic target for acute neuronal injury |
Q42229910 | Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury |
Q33948101 | Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. |
Q34270984 | Caspase-3 apoptotic signaling following injury to the central nervous system. |
Q48761262 | Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats |
Q36873699 | Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage |
Q34285326 | Cerebral resuscitation after traumatic brain injury and cardiopulmonary arrest in infants and children in the new millennium |
Q90328631 | Cerebrospinal Fluid Biomarkers Are Associated With Glial Fibrillary Acidic Protein and αII-spectrin Breakdown Products in Brain Tissues Following Penetrating Ballistic-Like Brain Injury in Rats |
Q42716996 | Cerebrospinal fluid protein biomarker panel for assessment of neurotoxicity induced by kainic acid in rats |
Q28363748 | Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain |
Q28390792 | Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury |
Q43226789 | Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis |
Q43794814 | Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septo-hippocampal cultures |
Q36424343 | Current status of fluid biomarkers in mild traumatic brain injury |
Q28140984 | Cytochrome c release and caspase activation in traumatic axonal injury |
Q40597014 | Cytoskeletal protein degradation and neurodegeneration evolves differently in males and females following experimental head injury |
Q37132873 | Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment |
Q35252148 | Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions |
Q58115503 | Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: marker for neuronal apoptosis |
Q34580757 | Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions |
Q36623896 | Effect of glutamate on lysosomal membrane permeabilization in primary cultured cortical neurons |
Q82341156 | Effects of camptothecin, etoposide and Ca2+ on caspase-3 activity and myofibrillar disruption of chicken during postmortem ageing |
Q42624770 | Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. |
Q36293416 | Extensive but coordinated reorganization of the membrane skeleton in myofibers of dystrophic (mdx) mice |
Q34230296 | Gene expression in neurotrauma |
Q48663347 | High-density microarray analysis of hippocampal gene expression following experimental brain injury. |
Q35131093 | Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products. |
Q57839949 | Huntingtin proteolysis in Huntington disease |
Q37724782 | Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury. |
Q33935231 | Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates |
Q36079904 | In vitro stretch injury induces time- and severity-dependent alterations of STEP phosphorylation and proteolysis in neurons |
Q51074009 | Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides neuroprotection. |
Q28505053 | Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus |
Q43764329 | Inhibition of calpain-mediated apoptosis by E-64 d-reduced immediate early gene (IEG) expression and reactive astrogliosis in the lesion and penumbra following spinal cord injury in rats |
Q48375680 | Inhibition of caspase-mediated apoptosis by peroxynitrite in traumatic brain injury. |
Q40220681 | Initial biological qualification of SBDP-145 as a biomarker of compound-induced neurodegeneration in the rat. |
Q37331844 | Investigation of nerve injury through microfluidic devices |
Q28383558 | Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury |
Q35182059 | Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay |
Q34374927 | Mechanical strain injury increases intracellular sodium and reverses Na+/Ca2+ exchange in cortical astrocytes |
Q44918318 | Mechanoporation induced by diffuse traumatic brain injury: an irreversible or reversible response to injury? |
Q33608570 | Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates |
Q47576972 | Mice overexpressing human caspase 3 appear phenotypically normal but exhibit increased apoptosis and larger lesion volumes in response to transient focal cerebral ischaemia. |
Q45074714 | Mild fluid percussion injury induces diffuse axonal damage and reactive synaptic plasticity in the mouse olfactory bulb |
Q37694465 | Minding the brain*. |
Q36045235 | Neuroprotection and acute spinal cord injury: a reappraisal |
Q34119497 | Neuroprotection by caspase inhibitors |
Q37428030 | Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats. |
Q37598421 | Novel Bioinformatics-Based Approach for Proteomic Biomarkers Prediction of Calpain-2 &Caspase-3 Protease Fragmentation: Application to βII-Spectrin Protein |
Q33180008 | Novel characteristics of glutamate-induced cell death in primary septohippocampal cultures: relationship to calpain and caspase-3 protease activation |
Q48487232 | Novel differential neuroproteomics analysis of traumatic brain injury in rats |
Q34627266 | Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury |
Q57839850 | Pretreatment with Calpain Inhibitor CEP-4143 Inhibits Calpain I Activation and Cytoskeletal Degradation, Improves Neurological Function, and Enhances Axonal Survival After Traumatic Spinal Cord Injury |
Q34275921 | Proteinase families and their inhibitors |
Q35692390 | Proteolysis of submembrane cytoskeletal proteins ankyrin-G and αII-spectrin following diffuse brain injury: a role in white matter vulnerability at Nodes of Ranvier |
Q34010369 | Recent advances in neurotrauma |
Q48864361 | Regional expression of Bcl-2 mRNA and mitochondrial cytochrome c release after experimental brain injury in the rat. |
Q40756960 | Serum deprivation increases ceramide levels and induces apoptosis in undifferentiated HN9.10e cells |
Q33408828 | Spillway-induced salmon head injury triggers the generation of brain alphaII-spectrin breakdown product biomarkers similar to mammalian traumatic brain injury |
Q73616946 | Staurosporine-induced neuronal death: multiple mechanisms and methodological implications |
Q73258448 | Synthesis, assembly, and turnover of alpha and beta-erythroid and nonerythroid spectrins in rat hippocampal neurons |
Q48228091 | Temporal assessment of caspase activation in experimental models of focal and global ischemia |
Q38723317 | The Next Generation of Biomarker Research in Spinal Cord Injury. |
Q28397332 | The potential for bio-mediators and biomarkers in pediatric traumatic brain injury and neurocritical care |
Q48489749 | The role of extracellular signal-regulated kinase in cognitive and motor deficits following experimental traumatic brain injury |
Q35102824 | To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways |
Q73011059 | Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals |
Q33793699 | Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats |
Q36026579 | Water soluble RNA based antagonist of AMPA receptors |
Q48516598 | boc-Aspartyl(OMe)-fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats |
Search more.